Phytotoxicity study of flumioxazin and its combinations with different adjuvants in sunflower cultivars von Torma, M.(Szeged University of Sciences, College of Agriculture, Hódmezõvásárhely), Horn, A.(Summit-Agro Hungaria Kft., Budapest), Hódi, L.(Plant and Soil Protection Service of Csongrád County, Hódmezõvásárhely), Kristó, I.(Szeged University of Sciences, College of Agriculture, Hódmezõvásárhely), Hódi-Szél, M.(Szeged University of Sciences, College of Agriculture, Hódmezõvásárhely)

Volltext

Removal of pollutants from drinking water by combined ion exchange and adsorption methods von Hódi, M., Polyák, K., Hlavay, J.

Volltext

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial von Margolin, Kim, Prof, Ernstoff, Marc S, MD, Hamid, Omid, MD, Lawrence, Donald, MD, McDermott, David, MD, Puzanov, Igor, MD, Wolchok, Jedd D, MD, Clark, Joseph I, Prof, Sznol, Mario, MD, Logan, Theodore F, MD, Richards, Jon, MD, Michener, Tracy, PharmD, Balogh, Agnes, MS, Heller, Kevin N, MD, Hodi, F Stephen, MD

Volltext

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial von Weber, Jeffrey S, Dr, D'Angelo, Sandra P, MD, Minor, David, MD, Hodi, F Stephen, MD, Gutzmer, Ralf, MD, Neyns, Bart, MD, Hoeller, Christoph, MD, Khushalani, Nikhil I, MD, Miller, Wilson H, MD, Lao, Christopher D, MD, Linette, Gerald P, MD, Thomas, Luc, MD, Lorigan, Paul, FRCP, Grossmann, Kenneth F, MD, Hassel, Jessica C, MD, Maio, Michele, MD, Sznol, Mario, MD, Ascierto, Paolo A, MD, Mohr, Peter, MD, Chmielowski, Bartosz, MD, Bryce, Alan, MD, Svane, Inge M, MD, Grob, Jean-Jacques, MD, Krackhardt, Angela M, MD, Horak, Christine, PhD, Lambert, Alexandre, PhD, Yang, Arvin S, MD, Larkin, James, FRCP

Volltext

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial von Ribas, Antoni, Prof, Puzanov, Igor, MD, Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Hamid, Omid, MD, Robert, Caroline, Prof, Hodi, F Stephen, MD, Schachter, Jacob, Prof, Pavlick, Anna C, MD, Lewis, Karl D, MD, Cranmer, Lee D, MD, Blank, Christian U, MD, O'Day, Steven J, MD, Ascierto, Paolo A, Prof, Salama, April K S, MD, Margolin, Kim A, Prof, Loquai, Carmen, MD, Eigentler, Thomas K, MD, Gangadhar, Tara C, MD, Carlino, Matteo S, MBBS, Agarwala, Sanjiv S, Prof, Moschos, Stergios J, MD, Sosman, Jeffrey A, Prof, Goldinger, Simone M, MD, Shapira-Frommer, Ronnie, MD, Gonzalez, Rene, Prof, Kirkwood, John M, Prof, Wolchok, Jedd D, Prof, Eggermont, Alexander, Prof, Li, Xiaoyun Nicole, PhD, Zhou, Wei, PhD, Zernhelt, Adriane M, BS, Lis, Joy, BSN, Ebbinghaus, Scot, MD, Kang, S Peter, MD, Daud, Adil, Prof

Volltext

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial von Robert, Caroline, Prof, Ribas, Antoni, Prof, Wolchok, Jedd D, Prof, Hodi, F Stephen, MD, Hamid, Omid, MD, Kefford, Richard, Prof, Weber, Jeffrey S, Prof, Joshua, Anthony M, PhD, Hwu, Wen-Jen, Prof, Gangadhar, Tara C, MD, Patnaik, Amita, MD, Dronca, Roxana, MD, Zarour, Hassane, Prof, Joseph, Richard W, MD, Boasberg, Peter, MD, Chmielowski, Bartosz, MD, Mateus, Christine, MD, Postow, Michael A, MD, Gergich, Kevin, MA, Elassaiss-Schaap, Jeroen, PhD, Li, Xiaoyun Nicole, PhD, Iannone, Robert, MD, Ebbinghaus, Scot W, MD, Kang, S Peter, MD, Daud, Adil, Prof

Volltext

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group von Lin, Nancy U, Dr, Lee, Eudocia Q, MD, Aoyama, Hidefumi, Prof, Barani, Igor J, MD, Baumert, Brigitta G, Prof, Brown, Paul D, Prof, Camidge, D Ross, MD, Chang, Susan M, Prof, Dancey, Janet, Prof, Gaspar, Laurie E, Prof, Harris, Gordon J, Prof, Hodi, F Stephen, MD, Kalkanis, Steven N, MD, Lamborn, Kathleen R, Prof, Linskey, Mark E, Prof, Macdonald, David R, MD, Margolin, Kim, Prof, Mehta, Minesh P, MD, Schiff, David, Prof, Soffietti, Riccardo, Prof, Suh, John H, Prof, van den Bent, Martin J, Prof, Vogelbaum, Michael A, Prof, Wefel, Jeffrey S, PhD, Wen, Patrick Y, Prof

Volltext

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group von Lin, Nancy U, Dr, Wefel, Jeffrey S, PhD, Lee, Eudocia Q, MD, Schiff, David, Prof, van den Bent, Martin J, Prof, Soffietti, Riccardo, Prof, Suh, John H, Prof, Vogelbaum, Michael A, Prof, Mehta, Minesh P, MD, Dancey, Janet, Prof, Linskey, Mark E, Prof, Camidge, D Ross, MD, Aoyama, Hidefumi, Prof, Brown, Paul D, Prof, Chang, Susan M, Prof, Kalkanis, Steven N, MD, Barani, Igor J, MD, Baumert, Brigitta G, Prof, Gaspar, Laurie E, Prof, Hodi, F Stephen, MD, Macdonald, David R, MD, Wen, Patrick Y, Prof

Volltext

Response assessment criteria for brain metastases: proposal from the RANO group von Lin, Nancy U, Dr, Lee, Eudocia Q, MD, Aoyama, Hidefumi, Prof, Barani, Igor J, MD, Barboriak, Daniel P, Prof, Baumert, Brigitta G, MD, Bendszus, Martin, Prof, Brown, Paul D, Prof, Camidge, D Ross, MD, Chang, Susan M, Prof, Dancey, Janet, Prof, de Vries, Elisabeth G E, Prof, Gaspar, Laurie E, Prof, Harris, Gordon J, Prof, Hodi, F Stephen, MD, Kalkanis, Steven N, MD, Linskey, Mark E, Prof, Macdonald, David R, MD, Margolin, Kim, Prof, Mehta, Minesh P, Prof, Schiff, David, Prof, Soffietti, Riccardo, Prof, Suh, John H, Prof, van den Bent, Martin J, Prof, Vogelbaum, Michael A, Prof, Wen, Patrick Y, Prof

Volltext

Multicenter evaluation of the tolerability of combined treatment with PD-1 and CTLA-4 immune checkpoint inhibitors and palliative radiotherapy von Bang, Andrew, MD, Wilhite, Tyler J., MD, Pike, Luke, MD DPhil, Cagney, Daniel N., MD, Aizer, Ayal A., MD, Taylor, Allison, MA, Spektor, Alexander, MD PhD, Krishnan, Monica, MD, Ott, Patrick A., MD PhD, Balboni, Tracy A., MD MPH, Hodi, F. Stephen, MD, Schoenfeld, Jonathan D., MD MPH

Volltext

CARBUTAMIDE von Csapó, G., Hódi, M.

Volltext

LOCAL INSULIN FOR DIABETICS' WOUNDS von CSAPO, G

Volltext

Removal of Pollutants from Drinking Water by Combined Ion Exchange and Absorption Methods von Hodi, M, Polyak, K, Hlavay, J

Volltext

A Szombathely II. sz. furas pannoniai (s.l.) Mollusca faunaja von KORPASNE HODI, M

Volltext

Metabolomic adaptations and correlates of survival to immune checkpoint blockade von Li, Haoxin, Bullock, Kevin, Gurjao, Carino, Braun, David, Shukla, Sachet A., Bossé, Dominick, Lalani, Aly-Khan A., Gopal, Shuba, Jin, Chelsea, Horak, Christine, Wind-Rotolo, Megan, Signoretti, Sabina, McDermott, David F., Freeman, Gordon J., Van Allen, Eliezer M., Schreiber, Stuart L., Stephen Hodi, F., Sellers, William R., Garraway, Levi A., Clish, Clary B., Choueiri, Toni K., Giannakis, Marios

Volltext

PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course von Nishino, Mizuki, Ramaiya, Nikhil H, Awad, Mark M, Sholl, Lynette M, Maattala, Jennifer A, Taibi, Myriam, Hatabu, Hiroto, Ott, Patrick A, Armand, Philippe F, Hodi, F Stephen

Volltext

Improved Endpoints for Cancer Immunotherapy Trials von Hoos, Axel, Eggermont, Alexander M. M., Janetzki, Sylvia, Hodi, F. Stephen, Ibrahim, Ramy, Anderson, Aparna, Humphrey, Rachel, Blumenstein, Brent, Old, Lloyd, Wolchok, Jedd

Volltext

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity von Ferrari de Andrade, Lucas, Tay, Rong En, Pan, Deng, Luoma, Adrienne M, Ito, Yoshinaga, Badrinath, Soumya, Tsoucas, Daphne, Franz, Bettina, May, Jr, Kenneth F, Harvey, Christopher J, Kobold, Sebastian, Pyrdol, Jason W, Yoon, Charles, Yuan, Guo-Cheng, Hodi, F Stephen, Dranoff, Glenn, Wucherpfennig, Kai W

Volltext

PD-L1 expression in nonclear-cell renal cell carcinoma von Choueiri, T.K., Fay, A.P., Gray, K.P., Callea, M., Ho, T.H., Albiges, L., Bellmunt, J., Song, J., Carvo, I., Lampron, M., Stanton, M.L., Hodi, F.S., McDermott, D.F., Atkins, M.B., Freeman, G.J., Hirsch, M.S., Signoretti, S.

Volltext

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma von Schadendorf, Dirk, Hodi, F Stephen, Robert, Caroline, Weber, Jeffrey S, Margolin, Kim, Hamid, Omid, Patt, Debra, Chen, Tai-Tsang, Berman, David M, Wolchok, Jedd D

Volltext